Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

NCT05221021 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

152

Enrollment

FED

Sponsor class

Conditions

Overactive Bladder Syndrome

Interventions

DRUG: Vaginal estrogen
DRUG: Mirabegron 50 MG [Myrbetriq]

Sponsor

Walter Reed National Military Medical Center